Skip to main content

Table 7 The 10 top-ranked compounds as drug targets for ALK, EGLN3, and NUAK1.

From: Genes associated with genotype-specific DNA methylation in squamous cell carcinoma as candidate drug targets

DrugBank ID

Compound name

Representative target cancer genes

 

ALK

 

DB01933

7-Hydroxystaurosporine

PDK1

DB08700

3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]

ALK, c-MET, LCK,

 

-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine

TRKA, TRKB, TIE2, ABL

DB04651

BIOTINOL-5-AMP

--

DB02491

4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N

FGFR2

 

-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine

 

DB07006

9-HYDROXY-6-(3-HYDROXYPROPYL)-4

WEE1

 

-(2-METHOXYPHENYL)PYRROLO[3,4-C]

 
 

CARBAZOLE-1,3(2H,6H)-DIONE

 

DB02010

Staurosporine

ITK, SYK, MAPKAPK2, GSK3,

  

CSK, CDK, PIK3CG, ZAP-70

DB02654

6-Hydroxy-Flavin-Adenine Dinucleotide

--

DB07460

2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN

ALK, PTK2

 

-4-YLPHENYL)AMINO]PYRIMIDIN-4

 
 

-YL}AMINO)-N-METHYLBENZAMIDE

 

DB07186

4-(4-METHYLPIPERAZIN-1-YL)-N-[5

AURKA, PLK1

 

-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO

 
 

[3,4-C]PYRAZOL-3-YL]BENZAMIDE

 

DB03247

Riboflavin Monophosphate

RPS6KA4, POR(P450), SGK1,

  

NOS1, DPYD, DHODH

 

EGLN3 (with Fe)

 

DB03702

2-[4-[[(S)-1-[[(S)-2-[[(Rs)-3,3,3-Trifluoro-1-Isopropyl-2

CELA1

 

-Oxopropyl]Aminocarbonyl]Pyrrolidin-1-Yl-]Carbonyl]-2

 
 

-Methylpropyl]Aminocarbonyl]Benzoylamino]Acetic Acid

 

DB04761

PYRIMIDINE-4,6-DICARBOXYLIC ACID

MMP13

 

BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]

 

DB08687

N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)

EGLN1, PHD2

 

CARBONYL]GLYCINE

 

DB08131

2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H

thyA

 

-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]

 
 

-BENZOYLAMINO}-3-METHYL-BUTYRIC ACID

 

DB02718

5-Formyl-6-Hydrofolic Acid

--

DB02015

Dihydrofolic Acid

--

DB02031

(6s)-5,6,7,8-Tetrahydrofolate

NOS1, thyA

DB04760

PYRIMIDINE-4,6-DICARBOXYLIC ACID

MMP13

 

BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)

 

DB04759

PYRIMIDINE-4,6-DICARBOXYLIC ACID

MMP13

 

BIS-(3-METHYL-BENZYLAMIDE)

 

DB07112

N-[(4-HYDROXY-8-IODOISOQUINOLIN-3-YL)

EGLN1, PHD2

 

CARBONYL]GLYCINE

 
 

EGLN3 (without Fe)

 

DB08687

N-[(1-CHLORO-4-HYDROXYISOQUINOLIN

EGLN1, PHD2, HIF1A

 

-3-YL)CARBONYL]GLYCINE

 

DB03702

already listed in EGLN3 (with Fe)

 

DB04759

already listed in EGLN3 (with Fe)

 

DB03625

5,10-Dideazatetrahydrofolic Acid

GARFTase

DB04760

already listed in EGLN3 (with Fe)

 

DB07112

already listed in EGLN3 (with Fe)

 

DB02015

already listed in EGLN3 (with Fe)

 

DB03541

10-Propargyl-5,8-Dideazafolic Acid

TYMS, DHFR

DB00158

Folic Acid

--

DB04761

already listed in EGLN3 (with Fe)

 
 

NUAK1

 

DB08053

1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H

CSF1R and others

 

-pyrazolo[3,4-d]pyrimidin-4-amine

 

DB08052

1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)

CSF1R and others

 

-1H-pyrazolo[3,4-d]pyrimidin-4-amine

 

DB08054

1-(1-methylethyl)-3-quinolin-6-yl-1H

CSF1R and others

 

-pyrazolo[3,4-d]pyrimidin-4-amine

 

DB07563

1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)

CTSK

 

benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine

 

DB08035

1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)

AR

 

-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE

 

DB04463

3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]

CBR1

 

Pyrimidin-3-Yl)Phenol

 

DB08300

1-methyl-3-naphthalen-2-yl-1H-pyrazolo

CSF1R and others

 

[3,4-d]pyrimidin-4-amine

 

DB01809

1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo

PKD1 and others

 

[3,4-D]Pyrimidin-4-Ylamine

 

DB08461

3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]

AR

 

PYRIMIDIN-3-YL)METHYL]PHENOL

 

DB08699

1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo

CAMK2G

 

[3,4-d]pyrimidin-4-amine

 
  1. The compounds were ranked based on FPAScores averaged over three independent trials and their representative target cancer genes. For the full lists of ranked compounds and a detailed discussion of the target cancer genes listed here, see Additional files 7 and 8, respectively. ALK and EGLN1, a paralog of EGLN3, are in bold letters. "―" indicates that no known cancer-associated genes are targeted by these compounds.